Here’s a breakdown of Ford’s Q4 2024 earnings. Although it sold a record over 97,000 electric vehicles last year, Ford was topped by cross-town rival GM as the number two seller of EVs in the US.

Adjusted EPS exceeded estimates, climbing to $0.14 from $0.08 in Q4 2023. Revenue surged by 36.2% year over year, reaching $828 million against a $775 million estimate. Cash from operations ...

Looking at Qualcomm’s peers in the processors and graphics chips segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Intel’s revenues decreased 7.4 ...

While major growth expectations weigh heavily on the decision of investors, Palantir's Earnings Surprise Percentage of -1.00% makes the minds of investors dubious. However, the Zacks Rank gives a ...

Amazon delivered a strong set of financial results in the fourth quarter, with revenue in the holiday span rising 10% from a year ago to $187.8 billion and earnings nearly doubling to $1.86.

Revenue for Q4 2024 was reported at $954 million, surpassing the estimate of $935 million. Q4 EPS came in at $2.62, exceeding the anticipated $2.40. The Companion Animal Group diagnostics segment ...

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal! The whispers are turning into roars.

YouTube’s record Q4 ad sales of $10.473 billion topped Wall Street analysts’ consensus estimate of $10.23 billion. That’s just one piece of YouTube’s business, not including subscription ...

Alphabet shares its Q4 2024 financial figures, including $96.5 billion in revenue. Search, YouTube, and cloud sales are all up, but cloud in specific fell short of analyst estimates. Stock prices ...

BofA expects Amazon to post strong Q4 results, with $187B sales and $19.7B GAAP operating profit. AWS growth forecast at 19-20%, while N.A. retail margins may expand to 7.0% on unit growth leverage.

The firm’s expenses for Q4 rose nearly 700% year-on-year to $1.1 billion as it started executing its “21/21 Plan” — targeting $42 billion in capital over the next three years, split equity ...

AbbVie Q4 adjusted EPS of $2.16 beat estimates, with strong sales of Skyrizi (+57.9%) and Rinvoq (+47.1%) boosting revenue growth. AbbVie raises 2027 revenue forecast for Skyrizi and Rinvoq to $31 ...